Similarly, the analysis of RFS, which covered eight cohorts, showed that the tumor patients with elevated CXCR7 expression level had significantly worse RFS compared to those with lower CXCR7 (HR 1.58, 95% CI 1.34–1.88, p < 0.001) (Fig. 5b). This evidence concerns the gene ACKR3 and neoplasm.